Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced that the US Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for POHERDY® ...
Lunsumio provides high rates of deep and long-lasting responses in third-line and later follicular lymphoma, a disease that ...
Researchers from Turku Bioscience Center at the University of Turku, Finland, have developed a new computational method to ...
New research finds college freshmen are getting better grades, but they’re also scoring lower on university entrance metrics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback